Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sen. Biden bill proposes to require government purchase of cocaine, heroin addiction treatments.

Executive Summary

SEN. BIDEN's ANTI-ADDICTION RESEARCH BILL would require the federal government to purchase patent rights to the first successful pharmaceutical treatments for cocaine and heroin addiction. Legislation (S 2051) introduced Sept. 3 by Sen. Biden (D-Del.), the ranking minority member of the Senate Judiciary Committee, would set into law the price tag for these patents: $100 mil. for a drug to treat cocaine addiction and $50 mil. for a heroin treatment.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028834

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel